Crocs expected to show underlying North America growth, analysts say
Crocs (CROX) is expected to report a 7% decline in North America direct-to-consumer sales for Q3, with Bank of America estimating 5% underlying growth excluding a revenue recognition change. The bank forecasts stronger wholesale sales to partly offset the impact. BofA maintains its buy rating, citing new products and stabilization in classic clogs. Crocs guided for 1% growth in brand sales and EPS of $3.20-$3.30.
How this was made
The 30-second read
Why it matters
Analyst forecast highlights a near‑term earnings risk but notes possible margin recovery and product pipeline strength.
Market read
The downgrade in Crocs' North America DTC sales could weigh on the stock ahead of its upcoming earnings report.
What to watch
Potential upside from new product pipeline and margin improvements may mitigate short‑term sales weakness.
Background
Crocs' recent revenue‑recognition change shifted a large partner from DTC to wholesale, prompting a temporary sales dip.
Ticker impact
Bank of America projects a 7% decline in Crocs' North America direct‑to‑consumer sales for Q3, with only 5% underlying growth after a revenue‑recognition change.
likely pressure as investors price in weaker direct‑to‑consumer growth.
The forecast signals a material sales contraction and margin pressure, which typically depresses the stock ahead of earnings.
Market effects
Footwear and apparel sector may see broader scrutiny of direct‑to‑consumer trends.
North America retail outlook could be tempered by Crocs' sales slowdown.
Limited; impact confined to Crocs and its immediate peers.
Counterpoint
If wholesale sales offset the DTC decline, the stock could be resilient.
Key entities
- companyCrocs, Inc.
Casual footwear maker (NASDAQ:CROX).
- analystBank of America
Provides the sales and earnings forecasts.
